Breaking News Instant updates and real-time market news.

BHC

Bausch Health

$22.89

0.455 (2.03%)

08:46
06/20/19
06/20
08:46
06/20/19
08:46

One of Bausch's key new drugs already facing generic challenge, says Wells Fargo

Wells Fargo analyst David Maris noted that an update posted on June 18 by the FDA revealed that a Paragraph IV challenge of Bausch Health's Bryhali was filed on March 20. The analyst, who explained that a Paragraph IV filing is made when a generic filer asserts either non-infringement or invalidity of branded product patents, called Bryhali one of Bausch's "key new drugs," noting that the company included it in what it has dubbed its "Significant Seven" products. A Paragraph IV filing does not mean a generic is imminent, said Maris, who also noted that such filings often result in settlements. The analyst, who said he is awaiting a reply from Bausch about this situation and whether it has sued the filing company, keeps an Underperform rating on Bausch Health shares.

BHC Bausch Health
$22.89

0.455 (2.03%)

05/13/19
05/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Royal Dutch Shell (RDS.A, RDS.B) upgraded to Buy from Hold at Deutsche Bank and HSBC. 2. KB Home (KBH) upgraded to Overweight from Equal Weight at Barclays with analyst Matthew Bouley saying his firm's spring agent survey confirmed that housing fundamentals have improved and stabilized. 3. Becton Dickinson (BDX) upgraded to Overweight from Equal Weight at Barclays with analyst Kristen Stewart saying the pullback in the shares since the FDA update on drug-coated balloons on March 15, coupled with the resetting of expectations following the company's Q2 results, provides an opportunity for investors. 4. Merck (MRK) upgraded to Overweight from Neutral at Atlantic Equities. 5. Bausch Health (BHC) upgraded to Neutral from Underweight at JPMorgan with analyst Chris Schott saying while a number of challenges remain in the story given the company's high leverage and controversial Xifaxan loss of exclusivity, its EBITDA is "clearly stabilizing and should begin to grow from here." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/19
WELS
05/17/19
NO CHANGE
WELS
Underperform
Bausch Q1 results similar to old Valeant business model, says Wells Fargo
Wells Fargo analyst David Maris says Bausch Health Companies' Q1 results demonstrate why the company reminds him a lot of the old Valeant and its price and deal driven model. The analyst adds that while some point to better than expected EBITDA, he sees low growth and high debt. Further, how price and deals contributed to Bausch's growth in Q1 is a reminder that "the more things have changed, the more they stay the same," Maris tells investors in a research note. In the press release, Bausch led with how Xifaxan grew 11%, but overall revenue growth of just 1% is not mentioned until the bottom of the press release, Maris points out. He keeps an Underperform rating on Bausch Health shares with a $9 price target.
06/11/19
LEHM
06/11/19
NO CHANGE
Target $28
LEHM
Overweight
Bausch Health transferred with an Overweight rating at Barclays
Barclays analyst Balaji Prasad took over coverage of Bausch Health Companies and keep an Overweight rating on the shares with a reduced price target of $28.
06/11/19
PIPR
06/11/19
NO CHANGE
Target $29
PIPR
Overweight
Piper Jaffray stays bullish on Bausch Health after analyzing volume trends
Piper Jaffray analyst David Amsellem stays bullish on shares of Bausch Health Companies after taking a closer look at volume trends for key new additions to the company's portfolio, such as Trulance and Bryhali. The trajectories on the whole are favorable through May, Amsellem tells investors in a research note. The analyst believes Bausch "continues to stand apart from the group of highly levered companies in the broader specialty pharma/generics space." This is due to the company's high visibility into "meaningful" longer-term EBITDA growth, says Amsellem, who keeps an Overweight rating on the shares with a $29 price target.

TODAY'S FREE FLY STORIES

FXI

iShares China Large-Cap ETF

$42.28

0.09 (0.21%)

10:20
07/17/19
07/17
10:20
07/17/19
10:20
Options
Short-term put buyer in China ETF bought delta neutral »

Short-term put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/17/19
07/17
10:17
07/17/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$45.50

0.78 (1.74%)

, OPRA

Opera

$11.00

0.41 (3.87%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

PAGS

PagSeguro Digital

$45.50

0.78 (1.74%)

OPRA

Opera

$11.00

0.41 (3.87%)

WORK

Slack Technologies

$34.19

-0.24 (-0.70%)

JLL

Jones Lang LaSalle

$140.23

-0.06 (-0.04%)

ALSN

Allison Transmission

$47.46

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

HSY

Hershey

$144.07

3.64 (2.59%)

, COP

ConocoPhillips

$60.31

0.57 (0.95%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

HSY

Hershey

$144.07

3.64 (2.59%)

COP

ConocoPhillips

$60.31

0.57 (0.95%)

CTRP

Ctrip

$38.35

1.48 (4.01%)

KBH

KB Home

$26.58

-0.16 (-0.60%)

SLGN

Silgan Holdings

$30.47

0.09 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

MFGP

Micro Focus

$21.23

0.57 (2.76%)

, WFC

Wells Fargo

$45.45

0.15 (0.33%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MFGP

Micro Focus

$21.23

0.57 (2.76%)

WFC

Wells Fargo

$45.45

0.15 (0.33%)

ARLP

Alliance Resource Partners

$16.87

-0.38 (-2.20%)

WUBA

58.com

$57.07

-0.68 (-1.18%)

RL

Ralph Lauren

$111.09

-4.07 (-3.53%)

LEVI

Levi Strauss

$18.76

-1.05 (-5.30%)

PVH

PVH Corp.

$89.89

-2.61 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

  • 19

    Sep

  • 12

    Oct

  • 15

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOYU

DouYu

$0.00

(0.00%)

10:15
07/17/19
07/17
10:15
07/17/19
10:15
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

LEVI

Levi Strauss

$18.74

-1.07 (-5.40%)

10:15
07/17/19
07/17
10:15
07/17/19
10:15
Options
Levi Strauss put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
07/17/19
07/17
10:15
07/17/19
10:15
General news
Fed funds futures have a light bid »

Fed funds futures have a…

10:15
07/17/19
07/17
10:15
07/17/19
10:15
General news
Breaking General news story  »

Week of 7/12 EIA…

DOYU

DouYu

$0.00

(0.00%)

10:13
07/17/19
07/17
10:13
07/17/19
10:13
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOYU

DouYu

$0.00

(0.00%)

10:09
07/17/19
07/17
10:09
07/17/19
10:09
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOYU

DouYu

$0.00

(0.00%)

10:05
07/17/19
07/17
10:05
07/17/19
10:05
Syndicate
DouYu indicated to open at $12.00, IPO priced at $11.50 »

DouYu (DOYU) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

TELL

Tellurian

$6.94

-0.74 (-9.64%)

10:05
07/17/19
07/17
10:05
07/17/19
10:05
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CTK

CooTek

$9.17

(0.00%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
CooTek falls -7.2% »

CooTek is down -7.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWB

Great Western

$32.31

-2.69 (-7.69%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Great Western falls -7.5% »

Great Western is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Sep

  • 11

    Sep

NUS

Nu Skin

$37.55

-7.95 (-17.47%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Nu Skin falls -17.4% »

Nu Skin is down -17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

NM

Navios Maritime

$5.64

0.3 (5.62%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Navios Maritime rises 5.8% »

Navios Maritime is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.36

0.185 (5.83%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Fortuna Silver Mines rises 5.8% »

Fortuna Silver Mines is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORN

Orion Group

$4.12

0.36 (9.57%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Orion Group rises 9.3% »

Orion Group is up 9.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TSLA

Tesla

$257.74

5.36 (2.12%)

09:57
07/17/19
07/17
09:57
07/17/19
09:57
Periodicals
Officials worry over Tesla's plan to unleash robo-cars, Washington Post says »

Tesla is racing to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

ABT

Abbott

$86.34

3.23 (3.89%)

09:56
07/17/19
07/17
09:56
07/17/19
09:56
Hot Stocks
Abbott says 'running as fast as we can in Europe' »

Says: Has paid down a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

KKR

KKR

$26.05

0.01 (0.04%)

09:55
07/17/19
07/17
09:55
07/17/19
09:55
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NCI

Navigant Consulting

$23.68

(0.00%)

09:55
07/17/19
07/17
09:55
07/17/19
09:55
Conference/Events
Senate Environment & Public Works Committee to hold a hearing »

The Senate Committee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 19

    Sep

09:55
07/17/19
07/17
09:55
07/17/19
09:55
Conference/Events
House Transportation & Intrastructure Committee to hold a hearing »

The Subcommittee on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.